IBT Staff Reporter

80701-80730 (out of 154954)

Sanofi says Genzyme takeover talks progressing

Sanofi-Aventis reported progress in talks to buy U.S. biotech Genzyme and predicted 5-10 percent lower earnings in 2011, underscoring the French drugmaker's need to find new sources of revenue growth.

Medtronic's MRI-safe pacemaker gets FDA nod

Medtronic Inc. (NYSE: MDT) said the U.S. Food and Drug Administration (FDA) approved its Revo MRI pacemaker - the first such device in the U.S. designed for safe use during certain magnetic resonance imaging (MRI) exams.

Stock futures tick lower ahead of Bernanke

U.S. stock index futures fell on Wednesday a day after the Dow posted its seventh consecutive advance in the year's lowest overall volume, possibly signaling the rally could be wilting.

Nissan Q3 falls but forecasts lifted on higher sales

Nissan Motor Co's <7201.T> quarterly profit fell 15 percent on a stronger yen and sliding Japanese demand, but the decline was the slimmest among local automakers and it lifted its outlook on growing overseas sales.

Coca-Cola volume strong

Coca-Cola Co reported higher-than-expected quarterly sales, helped by its third straight quarter of sales growth in North America.

Apple commences iPad 2 production

Word is out that the much awaited tablet from Apple camp; the iPad 2 is under production, confirming earlier reports claiming that tablet is due for launch in April.

Britain's LSE in deal to buy Toronto exchange

The London Stock Exchange is to buy Canada's TMX stock exchange operator to create the world's fourth-largest trading center and claw back some of the market share it has lost in recent years.

House panel chief sees no future in new $53 bln high-speed rail plan

The White House unveiled plans to spend $53 billion over the next six years on bringing high-speed rail service to 80 percent of Americans within 25 years, though House Transportation Committee chairman John Mica and Railroads Subcommittee chairman Bill Shuster expressed reservations over its future benefit.

Stocks set to open lower as rally flags

Wall Street was set for a slight fall on Wednesday, after a strong run that has taken share prices to their highest levels in more than two and a half years, and with investors awaiting the latest batch of earnings in a reporting season in which most companies have beaten forecasts.

Sanofi says Genzyme bid talks progressing

Sanofi-Aventis reported progress in talks to buy U.S. biotech Genzyme and predicted 5-10 percent lower earnings in 2011, underscoring the French drugmaker's need to find new sources of revenue growth.

New details on Battlefield 3 surface

Just days after DICE formally confirmed the 2011 fall release of Battlefield 3, the media is abuzz with reports on new leaked details and speculations.

Pages